Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 50 (RPL31P50)

Target
RPL31P50
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L31 pseudogene 50 (RPL31P50) is a human pseudogene corresponding to the ribosomal protein L31 gene family. Pseudogenes are segments of DNA that are similar to functional genes but are nonfunctional; they are typically produced by gene duplication or retrotransposition events and often lack the necessary regulatory elements or coding potential required for protein expression. RPL31P50 does not encode a functional protein and has no established role in human physiology or pathology. It is not considered a therapeutic or diagnostic target[11][12][14][16]. Key context: - RPL31P50 is not to be confused with the functional ribosomal protein L31 (RPL31), which participates in ribosome assembly and is upregulated in certain cancers[6][7]. - Several ribosomal protein genes have numerous processed pseudogenes scattered throughout the human genome, and RPL31P50 is one such example, with no coding capacity and no therapeutic relevance[1][11][16]. - No credible evidence links RPL31P50 to human disease mechanisms, drug interactions, or biomarker roles. In summary: RPL31P50 is a non-functional pseudogene, not an active molecular target for therapy or research purposes.

Other names
RPL31_16_1224hCG1644239RPL31P50
02

Biological functions

Other (no characterized biological function—pseudogenes generally lack active biological roles)
03

Disease associations

Other (no established role in disease; no association reported for this specific pseudogene)

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 50 (RPL31P50).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 50 (RPL31P50).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call